In Partnership with ATC Genomics, the Company Presented One of Asia's Largest Real-World Datasets (n=12,281) for AI-Powered ...

The research lays a foundation for the possibility that aggressive prostate cancer can probably be detected through a few drops of semen or blood in the long term. Prostate cancer is the most common ...

Gene Solutions announced its strategic entry into the Turkish market at the 2nd International Hereditary Cancers Congress (IHCC), held 05-08 February 2026 in Antalya. Show Full Article – In ...

In Partnership with ATC Genomics, the Company Presented One of Asia's Largest Real-World Datasets (n=12,281) for AI-Powered Multi-Cancer Early Detection (MCED) and Showcased its Clinically Validated ...

The team, which is led from Institut Imagine by Paul Bastard, will receive up to $25m over approximately five years to take on the challenge of cancer avoidance.

Founded by Practo's Shashank ND with Arpit Garg and Anshul Khandelwal, Cent combines advanced imaging, 120+ biomarkers and AI to detect cancer and cardiac risks before symptoms appear ...

Cambridge2Cambridge transatlantic company Mursla Bio is building on its US presence with its nextgen liver cancer ...

Transforming a nation of 1.4 billion people into the world's leading R&D hub is a monumental task. But by liberating the minds of the next generation of Indian scientists at 11, 12, and 13 years old, ...

What if doctors could tell you a disease was coming years before you felt a single symptom—and stop it in its tracks? That is ...

New research links Wnt signalling to aggressive paediatric liver cancer and chemoresistance. Learn what this means for treatment.

The personalized medicine biomarkers market offers significant opportunities driven by advancements in precision healthcare. Key opportunities include the widespread adoption in oncology and emerging ...